PeptiGen

AI platform for the development or de novo design of original and patentable peptide compounds with pharmacological activity

Artificial intelligence

platform

Design

We will create for you "turnkey" innovative compounds of peptide nature

R&D

We will conduct in vitro and in vivo tests to confirm the effectiveness of the developed substances — you will have a ready proof-of-concept

Generating

Our PeptiGen platform can generate at least 100,000,000 pharmacologically active peptides

About us

PeptiGen is a biotech startup. We a looking for partners

We have developed an innovative PeptiGen platform that generates unique and patentable peptide structures using artificial intelligence and machine learning methods. PeptiGen has already allowed the development of effective and investment-attractive compounds with antibacterial, antiviral and antitumor activity in vivo.

Services

Peptide Drug Design

Drug candidate

Creation or design of patentable candidates for medicines "turnkey" and for your needs

Proof-of-concept

Proof-of-concept for the developed peptide compounds: validation of effectiveness in vitro and in vivo

In silico peptide drug design

The PeptiGen AI/ML platform developed by us allows us to obtain pharmacologically active peptide compounds in vivo. At the same time, our platform allows us to increase the probability of obtaining a successful candidate for drugs – out of 5 synthesized compounds, at least 3 demonstrate high efficiency in vivo. That is, 60% of candidates are effective in animal models

Experience in in vitro and in vivo studies

We have learned how to quickly and efficiently screen the most promising compounds. Currently, we have methods for evaluating the antibacterial, antifungal, antiviral and antitumor effects of peptide compounds

Scientific expertise

Our team consists of professionals of early and late drug development. Expertise in the field of drug development, pharmacology and preclinical research is confirmed by federal grants and scientific publications. In addition, our team has experts in the field of machine learning and artificial intelligence who are working on the continuous improvement of the PeptiGen platform

Partners

We cooperate with commercial and scientific and educational institutions

Stavropol Research Anti-Plague Institute of Rospotrebnadzor – in vitro research of new antimicrobial antitumor compounds

We cooperate with the experimental vivarium, the Laboratory of Antimicrobial peptides, the Laboratory of Pharmacology and the Laboratory of Regenerative Medicine of Stavropol State Medical University to conduct in vivo research

NPO Immunotex is the official supplier of Cloud-Clone Corp, Elabscience Biotechnology Co, Ltd and BlueGene Biotech

The Center for Clinical Pharmacology and Pharmacotherapy is our partner in the field of antimicrobial compound testing

Call us by phone:+7 928 820 55 51

Write to us by email:info@peptigen.com